Company / Interest Expense
Merck & Co. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.1B
FY2023
5-year range
$806.0M / $1.1B
FY2019-FY2023
Trend
+19.1%
vs FY2022
Sector context
#5 of 44
Health Care
What the data says
Merck & Co.'s interest expense of $1.1B is higher than 89% of companies in the Health Care sector (FY2023). Increased from $806M to $1.1B over the past 2 years.
Based on SEC 10-K filings.
$1.1B in FY2023 with a 5-year CAGR of +8.2%. Top quartile in the Health Care sector.
Increased from $806M to $1.1B over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +11.3%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 44This company $1.1B Sector average $291.0M
▼
+293.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.2%, indicating consistent growth.
- In FY2023, interest expense increased 19.1% year-over-year.
- Ranks #5 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.1B | +19.1% |
| FY2022 | $962.0M | +19.4% |
| FY2021 | $806.0M | -3.0% |
| FY2020 | $831.0M | -6.9% |
| FY2019 | $893.0M | +15.7% |
| FY2018 | $772.0M | +2.4% |
| FY2017 | $754.0M | +8.8% |
| FY2016 | $693.0M | +3.1% |
As of FY2023 · SEC 10-K · Updated Mar 9, 2026